Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
š¼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SillaJen Inc (215600 KS)
Watchlist
52
Analysis
Health Care
ā¢
South Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
ā¢
Quantitative Analysis
ā¢
13 Sep 2019 08:23
Asia Short Interest - Scary Charts for Friday the 13th
In keeping with the day of the week and date, we look at some charts of short interest and price for stocks from Korea, Taiwan and Hong Kong.These...
Brian Freitas
Follow
912 Views
Share
bearish
ā¢
Quantitative Analysis
ā¢
04 Sep 2019 07:06
Korea Short Interest - SillaJen Tends to Zero
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 30 August.Current...
Brian Freitas
Follow
632 Views
Share
bearish
ā¢
Quantitative Analysis
ā¢
21 Aug 2019 05:40
Korea Short Interest - Numb3rs & Ch@rts
The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 16 August. Current...
Brian Freitas
Follow
640 Views
Share
bullish
ā¢
Icure Pharm Inc
ā¢
02 Jun 2018 11:48
Icure Pharm IPO Summary - Front Runner of Dementia Patch Development Race
Icure Pharm Inc (175250 KS)Ā will offer a total ofĀ 1,200,000 shares (100% new rights offering) atĀ ā©44,000 - ā©55,000 which gives a market cap of...
Sanghyun Park
Follow
453 Views
Share
bullish
ā¢
SillaJen Inc
ā¢
25 Oct 2017 14:03
SillaJen - Pipeline Review & Valuation Study
I surely understandĀ SillaJen, Inc. (0908477D KS) is a very speculative stock to invest right now. It has virtually no revenue. We still have to...
Sanghyun Park
Follow
533 Views
Share
First
Previous
5
6
7
8
9
10
11
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright Ā© 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x